SPEVIGO

Google image searchProduct monograph

Active ingredient

spesolimab, 150 MG/ML

DIN: 02550296

Dosage form(s): SOLUTION

Route(s) of administration: SUBCUTANEOUS

Description: PREFILLED SYRINGE - SINGLE USE

Schedule: Prescription / Schedule D

Company: BOEHRINGER INGELHEIM (CANADA) LTD LTEE

Date: 28-OCT-2024

ATC:

• L04 — IMMUNOSUPPRESSANTS (ATC, ATC/DDD, )
• L04A — IMMUNOSUPPRESSANTS (ATC, ATC/DDD)
• L04AC — Interleukin inhibitors (ATC, ATC/DDD)
• L04AC22 — SPESOLIMAB (ATC/DDD)

Pharmaceutical standard: MFR

External Links for Spevigo

Search on Google

• Spevigo side effects
• Spevigo dosage
• spesolimab side effects
• spesolimab dosage

Boehringer Ingelheim (Canada) Ltd Ltee

Go to Boehringer Ingelheim website to see drug product details. Sometimes you can find spevigo photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.